Lazard Asset Management’s Opko Health OPK Stock Holding History

Lazard Asset Management’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,609,314	Closed	-$5.99M	–	2466
2025 Q1	$5.99M	Buy	3,609,314 +1,060,647	+42%	+$1.75M	0.01%	626
2024 Q4	$3.75M	Buy	2,548,667 +1,502,342	+144%	+$2.3M	0.01%	709
2024 Q3	$1.56M	Buy	1,046,325 +214,119	+26%	+$318K	﹤0.01%	933
2024 Q2	$1.04M	Buy	832,206 +616,767	+286%	+$800K	﹤0.01%	966
2024 Q1	$258K	Buy	+215,439	New	+$216K	﹤0.01%	1223
2021 Q3	–	Sell	-15,396	Closed	-$62K	–	2252
2021 Q2	$62K	Buy	+15,396	New	+$60.4K	﹤0.01%	1509
2015 Q3	–	Sell	-78,350	Closed	-$1.26M	–	1132
2015 Q2	$1.26M	Hold	78,350	–	–	﹤0.01%	675
2015 Q1	$1.11M	Hold	78,350	–	–	﹤0.01%	699
2014 Q4	$782K	Hold	78,350	–	–	﹤0.01%	778
2014 Q3	$666K	Hold	78,350	–	–	﹤0.01%	725
2014 Q2	$692K	Hold	78,350	–	–	﹤0.01%	751
2014 Q1	$730K	Hold	78,350	–	–	﹤0.01%	706
2013 Q4	$661K	Buy	+78,350	New	+$792K	﹤0.01%	739

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Lazard Asset Management's OPK Position: Q2 2025 in Review

Lazard Asset Management sold out of Opko Health (OPK) in Q2 2025, closing a stake of 3,609,314 shares — an estimated $5.99M sold.

Lazard Asset Management first reported a position in OPK in Q4 2013 and held it in 13 quarters. The position peaked at $5.99M in Q1 2025. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2025.

Lazard Asset Management reported no remaining Opko Health position as of Q2 2025 after selling out during the quarter.
Lazard Asset Management sold 3,609,314 Opko Health shares in Q2 2025, an estimated $5.99M.
Lazard Asset Management first reported a position in Opko Health in Q4 2013 and held it in 13 quarters.
Lazard Asset Management's Opko Health position peaked at $5.99M in Q1 2025.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.